155 related articles for article (PubMed ID: 38302612)
1. METTL3 regulates TFRC ubiquitination and ferroptosis through stabilizing NEDD4L mRNA to impact stroke.
Su W; Yu X; Wang S; Wang X; Dai Z; Li Y
Cell Biol Toxicol; 2024 Feb; 40(1):8. PubMed ID: 38302612
[TBL] [Abstract][Full Text] [Related]
2. METTL3 silenced inhibited the ferroptosis development via regulating the TFRC levels in the Intracerebral hemorrhage progression.
Zhang L; Wang X; Che W; Zhou S; Feng Y
Brain Res; 2023 Jul; 1811():148373. PubMed ID: 37105375
[TBL] [Abstract][Full Text] [Related]
3. Melatonin alleviates ischemic stroke by inhibiting ferroptosis through the CYP1B1/ACSL4 pathway.
Sun Y; Jin H; He J; Lai J; Lin H; Liu X
Environ Toxicol; 2024 May; 39(5):2623-2633. PubMed ID: 38205686
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of METTL3 ameliorates doxorubicin-induced cardiotoxicity through suppression of TFRC-mediated ferroptosis.
Wu L; Du Y; Wang L; Zhang Y; Ren J
Redox Biol; 2024 Jun; 72():103157. PubMed ID: 38631119
[TBL] [Abstract][Full Text] [Related]
5. METTL3-mediated ANXA2 inhibition confers neuroprotection in ischemic stroke: Evidence from in vivo and in vitro studies.
Liu B; Xing Z; Song F; Li D; Zhao B; Xu C; Xia W; Ji H
FASEB J; 2023 Jul; 37(7):e22974. PubMed ID: 37249328
[TBL] [Abstract][Full Text] [Related]
6. METTL3-dependent N6-methyladenosine modification is involved in berberine-mediated neuroprotection in ischemic stroke by enhancing the stability of NEAT1 in astrocytes.
Hu J; Duan H; Zou J; Ding W; Wei Z; Peng Q; Li Z; Duan R; Sun J; Zhu J
Aging (Albany NY); 2024 Jan; 16(1):299-321. PubMed ID: 38180752
[TBL] [Abstract][Full Text] [Related]
7. YAP Facilitates NEDD4L-Mediated Ubiquitination and Degradation of ACSL4 to Alleviate Ferroptosis in Myocardial Ischemia-Reperfusion Injury.
Qiu M; Yan W; Liu M
Can J Cardiol; 2023 Nov; 39(11):1712-1727. PubMed ID: 37541340
[TBL] [Abstract][Full Text] [Related]
8. The N6-methyladenosine modification enhances ferroptosis resistance through inhibiting SLC7A11 mRNA deadenylation in hepatoblastoma.
Liu L; He J; Sun G; Huang N; Bian Z; Xu C; Zhang Y; Cui Z; Xu W; Sun F; Zhuang C; Man Q; Gu S
Clin Transl Med; 2022 May; 12(5):e778. PubMed ID: 35522946
[TBL] [Abstract][Full Text] [Related]
9. N6-methyladenosine writer METTL3 accelerates the sepsis-induced myocardial injury by regulating m6A-dependent ferroptosis.
Shen H; Xie K; Tian Y; Wang X
Apoptosis; 2023 Apr; 28(3-4):514-524. PubMed ID: 36645573
[TBL] [Abstract][Full Text] [Related]
10. METTL3 attenuates ferroptosis sensitivity in lung cancer via modulating TFRC.
Zhang P; Wang S; Chen Y; Yang Q; Zhou J; Zang W
Open Med (Wars); 2024; 19(1):20230882. PubMed ID: 38221933
[TBL] [Abstract][Full Text] [Related]
11. Silencing of METTL3 suppressed ferroptosis of myocardial cells by m6A modification of SLC7A11 in a YTHDF2 manner.
Tang Z; Huang X; Mei H; Zheng Z
J Bioenerg Biomembr; 2024 Apr; 56(2):149-157. PubMed ID: 38319402
[TBL] [Abstract][Full Text] [Related]
12. METTL3-mediated N6-methyladenosine modification stimulates mitochondrial damage and ferroptosis of kidney tubular epithelial cells following acute kidney injury by modulating the stabilization of MDM2-p53-LMNB1 axis.
Hu C; Zhang B; Zhao S
Eur J Med Chem; 2023 Nov; 259():115677. PubMed ID: 37542992
[TBL] [Abstract][Full Text] [Related]
13. METTL3-deficiency Suppresses Neural Apoptosis to Induce Protective Effects in Cerebral I/R Injury via Inhibiting RNA m6A Modifications: A Pre-clinical and Pilot Study.
Huang G; Qiu Y; Fan Y; Liu J
Neurochem Res; 2024 Jan; 49(1):85-98. PubMed ID: 37610605
[TBL] [Abstract][Full Text] [Related]
14. N6-Methyladenosine Methyltransferase METTL3 Alleviates Diabetes-Induced Testicular Damage through Modulating TUG1/Clusterin Axis.
Tian Y; Xiao YH; Sun C; Liu B; Sun F
Diabetes Metab J; 2023 Mar; 47(2):287-300. PubMed ID: 36653890
[TBL] [Abstract][Full Text] [Related]
15. METTL3 Mediates Microglial Activation and Blood-Brain Barrier Permeability in Cerebral Ischemic Stroke by Regulating NLRP3 Inflammasomes Through m6A Methylation Modification.
Cheng X; Ren Z; Jia H; Wang G
Neurotox Res; 2024 Feb; 42(1):15. PubMed ID: 38349604
[TBL] [Abstract][Full Text] [Related]
16. Methyltransferase-like 3 silenced inhibited the ferroptosis development via regulating the glutathione peroxidase 4 levels in the intracerebral hemorrhage progression.
Zhang L; Wang X; Che W; Yi Y; Zhou S; Feng Y
Bioengineered; 2022 Jun; 13(6):14215-14226. PubMed ID: 35758287
[TBL] [Abstract][Full Text] [Related]
17. Rhein attenuates cerebral ischemia-reperfusion injury via inhibition of ferroptosis through NRF2/SLC7A11/GPX4 pathway.
Liu H; Zhang TA; Zhang WY; Huang SR; Hu Y; Sun J
Exp Neurol; 2023 Nov; 369():114541. PubMed ID: 37714424
[TBL] [Abstract][Full Text] [Related]
18. Deletion of ubiquitin ligase Nedd4l exacerbates ischemic brain damage.
Kim T; Chokkalla AK; Vemuganti R
J Cereb Blood Flow Metab; 2021 May; 41(5):1058-1066. PubMed ID: 32703111
[TBL] [Abstract][Full Text] [Related]
19. O-GlcNAcylation regulates the stability of transferrin receptor (TFRC) to control the ferroptosis in hepatocellular carcinoma cells.
Zhou X; Wang Y; Li X; Zhou J; Yang W; Wang X; Jiao S; Zuo W; You Z; Ying W; Wu C; Bao J
Redox Biol; 2024 Jul; 73():103182. PubMed ID: 38744192
[TBL] [Abstract][Full Text] [Related]
20. Histone lactylation-regulated METTL3 promotes ferroptosis via m6A-modification on ACSL4 in sepsis-associated lung injury.
Wu D; Spencer CB; Ortoga L; Zhang H; Miao C
Redox Biol; 2024 Aug; 74():103194. PubMed ID: 38852200
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
